News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
359,895 Results
Type
Article (14362)
Company Profile (127)
Press Release (345406)
Section
Business (112608)
Career Advice (452)
Deals (18613)
Drug Delivery (27)
Drug Development (31147)
Employer Resources (49)
FDA (8791)
Job Trends (7666)
News (172723)
Policy (12355)
Tag
Academia (1314)
Alliances (34659)
Alzheimer's disease (459)
Approvals (8783)
Artificial intelligence (146)
Bankruptcy (129)
Best Places to Work (6490)
Biotechnology (95)
Breast cancer (78)
Cancer (654)
Career advice (403)
CAR-T (61)
Cell therapy (178)
Clinical research (24047)
Collaboration (361)
Compensation (67)
COVID-19 (1120)
C-suite (72)
Data (665)
Diabetes (59)
Diagnostics (4761)
Earnings (37909)
Events (50436)
Executive appointments (214)
FDA (9138)
Funding (277)
Gene editing (52)
Gene therapy (110)
GLP-1 (195)
Government (1227)
Healthcare (9856)
Infectious disease (1173)
IPO (7940)
Job creations (1437)
Job search strategy (360)
Layoffs (110)
Legal (2511)
Lung cancer (77)
Manufacturing (127)
Medical device (11355)
Medtech (11360)
Mergers & acquisitions (10814)
Metabolic disorders (143)
Neuroscience (576)
NextGen Class of 2024 (3532)
Non-profit (1515)
Northern California (756)
Obesity (68)
Opinion (68)
Patents (74)
People (32309)
Phase I (8867)
Phase II (10868)
Phase III (7039)
Pipeline (240)
Postmarket research (501)
Preclinical (4014)
Press Release (66)
Radiopharmaceuticals (149)
Rare diseases (100)
Real estate (3350)
Regulatory (9136)
Research institute (1266)
Resumes & cover letters (68)
Southern California (788)
Startups (2502)
United States (7762)
Vaccines (249)
Date
Today (55)
Last 7 days (298)
Last 30 days (1180)
Last 365 days (18738)
2024 (18642)
2023 (22099)
2022 (30820)
2021 (32529)
2020 (30553)
2019 (25810)
2018 (19471)
2017 (18871)
2016 (17761)
2015 (20562)
2014 (15177)
2013 (12742)
2012 (13786)
2011 (14073)
2010 (12830)
Location
Africa (314)
Arizona (98)
Asia (23736)
Australia (4127)
California (1876)
Canada (772)
China (150)
Colorado (115)
Connecticut (90)
Europe (48478)
Florida (289)
Georgia (92)
Illinois (199)
Indiana (110)
Japan (60)
Kansas (77)
Maryland (334)
Massachusetts (1318)
Michigan (152)
Minnesota (187)
New Hampshire (59)
New Jersey (593)
New York (533)
North Carolina (414)
Northern California (756)
Ohio (76)
Pennsylvania (390)
South America (504)
Southern California (788)
Texas (294)
Utah (64)
Washington State (248)
359,895 Results for "ibex technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
IBEX Shareholders Approve Sale of the Company
IBEX Technologies Inc. is pleased to announce that at an annual and special meeting held , IBEX shareholders approved the previously-announced proposed amalgamation of IBEX and 15720273 Canada Inc., a newly-incorporated wholly-owned subsidiary of BBI Solutions OEM Limited, whereby BBI will acquire all of the issued and outstanding shares of IBEX at a price of $1.45 per share in cash.
April 3, 2024
·
2 min read
IBEX Completes Sale of the Company
IBEX Technologies Inc. announces that it has completed the sale of the company by amalgamating with 15720273 Canada Inc., a newly-incorporated wholly-owned subsidiary of BBI Solutions OEM Limited.
April 8, 2024
·
2 min read
Business
IBEX Reports Results for the Second Quarter and Six Months Ended January 31, 2024
IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the second quarter and the six months ended January 31, 2024.
March 22, 2024
·
6 min read
Deals
IBEX Technologies Signs Definitive Agreement for Sale of the Company for $1.45 Cash Per Share
IBEX Technologies Inc. (“ IBEX ” or the “ Company ”) (TSX Venture: IBT) is pleased to announce that it has entered into a binding acquisition agreement dated February 9, 2024 (the “ Acquisition Agreement ”) and related agreements with 15720273 Canada Inc. (the “ Purchaser ”), a newly-incorporated, wholly-owned subsidiary of BBI Solutions OEM Limited (“ BBI ”), whereby BBI will acquire all of the issued and outstanding shares of IBEX at a price of $1.
February 12, 2024
·
7 min read
Press Releases
Prestigious Cancer Center Institut Curie Introduces Ibex Medical Analytics’ AI Tools for Cancer Diagnostics
November 21, 2024
·
3 min read
IBEX Files Addendum to Management Proxy Circular for Sale of the Company at $1.45 Per Share
IBEX Technologies Inc. announces that it has filed an addendum to its management proxy circular dated February 23, 2024 for the annual and special meeting of shareholders to be held in Montreal, Québec on April 3, 2024.
March 14, 2024
·
4 min read
Business
IBEX Reports Results for the First Quarter Ended October 31, 2023
IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the three months ended October 31, 2023.
December 14, 2023
·
5 min read
IBEX Technologies Announces Renewal of Normal Course Issuer Bid
IBEX Technologies Inc. announced that the TSX Venture Exchange has conditionally approved the renewal of IBEX’s normal course issuer bid.
July 17, 2023
·
3 min read
Business
Ibex Presents New Data from Multiple Studies Showcasing Accuracy of AI in Prostate, Breast and Gastric Cancer Diagnosis
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced excellent results across multiple clinical studies conducted with the University of Pittsburgh Medical Center (UPMC), Brigham and Women’s Hospital, Champalimaud Foundation and Ohio State University (OSU).
March 21, 2024
·
6 min read
IBEX Reports Results for the Year Ended July 31, 2023
IBEX Technologies Inc. reported its financial results for the fiscal year ended July 31, 2023.
November 9, 2023
·
8 min read
1 of 35,990
Next